Both integrated and differential regulation of components of the IL-2/IL-2 receptor system.

Interleukin-2 was discovered in 1976 as a T-cell growth factor. It was the first type I cytokine cloned and the first for which a receptor component was cloned. Its importance includes its multiple actions, therapeutic potential, and lessons for receptor biology, with three components differentially combining to form high, intermediate, and low-affinity receptors. IL-2Ralpha and IL-2Rbeta, respectively, are markers for double-negative thymocytes and regulatory T-cells versus memory cells. gamma(c), which is shared by six cytokines, is mutated in patients with X-linked severe-combined immunodeficiency. We now cover an under-reviewed area-the regulation of genes encoding IL-2 and IL-2R components, with an effort to integrate/explain this knowledge.

[1]  J. Gnarra,et al.  A 100-kilodalton protein is associated with the murine interleukin 2 receptor: biochemical evidence that p100 is distinct from the alpha and beta chains. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Waldmann,et al.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor , 1982, Nature.

[3]  I. Horak,et al.  Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting , 1991, Nature.

[4]  P. Ricciardi-Castagnoli,et al.  Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity , 2003, The EMBO journal.

[5]  R. Flavell,et al.  Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. , 1998, Immunity.

[6]  J. W. Rooney,et al.  Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation , 1995, Molecular and cellular biology.

[7]  W. Leonard,et al.  Signaling from the IL-2 receptor to the nucleus. , 1997, Cytokine & growth factor reviews.

[8]  S. L. Cross,et al.  Delineation of an enhancerlike positive regulatory element in the interleukin-2 receptor alpha-chain gene , 1990, Molecular and cellular biology.

[9]  W. Leonard,et al.  An IL‐2 response element in the human IL‐2 receptor alpha chain promoter is a composite element that binds Stat5, Elf‐1, HMG‐I(Y) and a GATA family protein. , 1996, The EMBO journal.

[10]  A. Lichtman,et al.  IL-4 induces IL-2 receptor p75 beta-chain gene expression and IL-2-dependent proliferation in mouse T lymphocytes. , 1992, Journal of immunology.

[11]  D. Olive,et al.  Novel CD28-Responsive Enhancer Activated by CREB/ATF and AP-1 Families in the Human Interleukin-2 Receptor α-Chain Locus , 2001, Molecular and Cellular Biology.

[12]  S. Galande,et al.  Displacement of SATB1-Bound Histone Deacetylase 1 Corepressor by the Human Immunodeficiency Virus Type 1 Transactivator Induces Expression of Interleukin-2 and Its Receptor in T Cells , 2005, Molecular and Cellular Biology.

[13]  D. Longo,et al.  Regulation by interleukin-2 (IL-2) and interferon gamma of IL-2 receptor gamma chain gene expression in human monocytes. , 1994, Blood.

[14]  M. Nabholz,et al.  Interleukin-2 (IL-2) Regulates the Accessibility of the IL-2-Responsive Enhancer in the IL-2 Receptor α Gene to Transcription Factors , 1999, Molecular and Cellular Biology.

[15]  M. Mann,et al.  Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. , 2000, Genes & development.

[16]  R. Homer,et al.  Essential Role of Nuclear Factor κB in the Induction of Eosinophilia in Allergic Airway Inflammation , 1998, The Journal of experimental medicine.

[17]  W. Leonard.  Cytokines and immunodeficiency diseases , 2001, Nature Reviews Immunology.

[18]  T. Waldmann,et al.  Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Becker,et al.  Negative transcriptional regulation in anergic T cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Ronald H. Schwartz,et al.  IL-2 Secretion by CD4+ T Cells In Vivo Is Rapid, Transient, and Influenced by TCR-Specific Competition , 2004, The Journal of Immunology.

[21]  F. Birg,et al.  CD28 costimulation up-regulates long-term IL-2R beta expression in human T cells through combined transcriptional and post-transcriptional regulation. , 1995, Journal of immunology.

[22]  P. Koskinen,et al.  Interferon- Activates Multiple STAT Proteins and Upregulates Proliferation-Associated IL-2R, c-myc, and pim-1 Genes in Human T Cells , 1999 .

[23]  E. Wagner,et al.  JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development , 1999, Current Biology.

[24]  R. Gibbs,et al.  PipMaker--a web server for aligning two genomic DNA sequences. , 2000, Genome research.

[25]  V. Sukhatme,et al.  Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. , 1995, Progress in nucleic acid research and molecular biology.

[26]  J. Pouysségur,et al.  Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications. , 2005, Cellular signalling.

[27]  S. Spicuglia,et al.  Control of IL-2Rα gene expression: structural changes within the proximal enhancer/core promoter during T-cell development , 2002 .

[28]  P. Zipfel,et al.  A Regulatory Element in the Human Interleukin 2 Gene Promoter Is a Binding Site for the Zinc Finger Proteins Sp1 and EGR-1 (*) , 1995, The Journal of Biological Chemistry.

[29]  T. Taniguchi,et al.  Structure and expression of a cloned cDNA for human interleukin-2 , 1983, Nature.

[30]  T. Taniguchi,et al.  Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. , 1989, Science.

[31]  B. Franza,et al.  The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV , 1988, Cell.

[32]  N. Wu,et al.  A negative regulatory element-dependent inhibitory role of ITF2B on IL-2 receptor α gene ☆ ☆☆ , 2005 .

[33]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[34]  A. Wells,et al.  Signals from CD28 Induce Stable Epigenetic Modification of the IL-2 Promoter1 , 2005, The Journal of Immunology.

[35]  W. Leonard,et al.  Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins , 1995, Molecular and cellular biology.

[36]  W. Leonard,et al.  Calcium-dependent Activation of Interleukin-21 Gene Expression in T Cells* , 2005, Journal of Biological Chemistry.

[37]  W. Gerald,et al.  Induction of the interleukin-2/15 receptor β-chain by the EWS–WT1 translocation product , 2002, Oncogene.

[38]  Richard A Flavell,et al.  Transforming growth factor-beta regulation of immune responses. , 2006, Annual review of immunology.

[39]  W. Leonard,et al.  The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites , 1997, Molecular and cellular biology.

[40]  T. Steitz,et al.  Sequence-specific recognition of DNA by zinc-finger peptides derived from the transcription factor Sp1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  W. Leonard,et al.  Sp1 represses IL-2 receptor alpha chain gene expression. , 1990, The New biologist.

[42]  D. Olive,et al.  In vivo regulation of interleukin‐2 receptor alpha gene transcription by the coordinated binding of constitutive and inducible factors in human primary T cells. , 1995, The EMBO journal.

[43]  A. Cogoli,et al.  Early immune response and regulation of IL-2 receptor subunits. , 2005, Cellular signalling.

[44]  R. Flavell,et al.  c-Jun NH2-Terminal Kinase (JNK)1 and JNK2 Have Distinct Roles in CD8+ T Cell Activation , 2002, The Journal of experimental medicine.

[45]  A. Weiss,et al.  CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites , 1997, Molecular and cellular biology.

[46]  T. Malek,et al.  Tolerance, not immunity, crucially depends on IL-2 , 2004, Nature Reviews Immunology.

[47]  M. Fresno,et al.  Regulation of interleukin-2 receptor alpha chain expression and nuclear factor.kappa B activation by protein kinase C in T lymphocytes. Autocrine role of tumor necrosis factor alpha. , 1994, The Journal of biological chemistry.

[48]  J. Darnell,et al.  The state of the STATs: recent developments in the study of signal transduction to the nucleus. , 1997, Current opinion in cell biology.

[49]  W. Leonard,et al.  Mechanisms and Biological Consequences of STAT Signaling by Cytokines that Share the Common Cytokine Receptor γ Chain, γc , 2003 .

[50]  G. Crabtree,et al.  Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40. , 1991, Science.

[51]  L. Glimcher,et al.  Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. , 1996, Immunity.

[52]  T. Kadesch,et al.  Transcriptional repression of the IL-2 gene in Th cells by ZEB. , 1998, Journal of immunology.

[53]  W. Leonard,et al.  Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. , 1993, Journal of immunology.

[54]  M. F. Shannon,et al.  High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters. , 1996, Immunity.

[55]  W. Leonard,et al.  The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling. , 1996, Annual review of medicine.

[56]  M. Waterman,et al.  Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions. , 1998, Nucleic acids research.

[57]  C Terhorst,et al.  Monoallelic expression of the interleukin-2 locus. , 1998, Science.

[58]  N. Tanaka,et al.  Functional Analysis of the Human Interleukin 2 Receptor γ Chain Gene Promoter (*) , 1995, The Journal of Biological Chemistry.

[59]  K. Sugamura,et al.  Expression of the IL-2 receptor γ chain on various populations in human peripheral blood , 1994 .

[60]  S. Ng,et al.  CD28-costimulation activates cyclic AMP-responsive element-binding protein in T lymphocytes. , 1997, Journal of immunology.

[61]  U. Rapp,et al.  The GABP-responsive Element of the Interleukin-2 Enhancer Is Regulated by JNK/SAPK-activating Pathways in T Lymphocytes* , 1998, The Journal of Biological Chemistry.

[62]  H. Griesser,et al.  Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. , 1995, Science.

[63]  R. Schwartz,et al.  CD28-Mediated regulation of mRNA stability requires sequences within the coding region of the IL-2 mRNA. , 1999, Journal of immunology.

[64]  T. Kohwi-Shigematsu,et al.  SATB1 targets chromatin remodelling to regulate genes over long distances , 2002, Nature.

[65]  S. Ziegler,et al.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. , 1993, Science.

[66]  R. Paredes,et al.  The potential role of interleukin-2 in patients with HIV infection. , 2002, AIDS reviews.

[67]  T. Honjo,et al.  Molecular cloning of cDNA encoding human interleukin-2 receptor , 1984, Nature.

[68]  L. Fiette,et al.  IL-2 receptor alpha-chain expression is independently regulated in primary and secondary lymphoid organs. , 1998, Journal of immunology.

[69]  P. Bucher,et al.  Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor alpha gene , 1996, Molecular and cellular biology.

[70]  R. Flavell,et al.  Defective T cell differentiation in the absence of Jnk1. , 1998, Science.

[71]  T. Waldmann.  The multi-subunit interleukin-2 receptor. , 1989, Annual review of biochemistry.

[72]  P. Lemaire,et al.  Characterization of a mouse multigene family that encodes zinc finger structures , 1988, Molecular and cellular biology.

[73]  F. Brombacher,et al.  IL-2 promoter-driven lacZ expression as a monitoring tool for IL-2 expression in primary T cells of transgenic mice. , 1994, International immunology.

[74]  D. Frasca,et al.  Inhibition of IL-2 production by Nil-2-a in murine T cells. , 1998, International immunology.

[75]  R. Schwartz,et al.  The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy. , 1999, Journal of immunology.

[76]  W. Leonard,et al.  The basis for TCR‐mediated regulation of the IL‐2 receptor α chain gene: role of widely separated regulatory elements , 2002, The EMBO journal.

[77]  N. Tanaka,et al.  Cloning of the gamma chain of the human IL-2 receptor. , 1992, Science.

[78]  A. Feller,et al.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.

[79]  U. Rapp,et al.  GABP factors bind to a distal interleukin 2 (IL-2) enhancer and contribute to c-Raf-mediated increase in IL-2 induction , 1997, Molecular and cellular biology.

[80]  M. Miyasaka,et al.  In utero treatment with monoclonal antibody to IL-2 receptor beta-chain completely abrogates development of Thy-1+ dendritic epidermal cells. , 1992, International Immunology.

[81]  W. Leonard,et al.  The Common Cytokine Receptor γ Chain Plays an Essential Role in Regulating Lymphoid Homeostasis , 1997, The Journal of experimental medicine.

[82]  M. Jenkins,et al.  CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. , 1991, Journal of immunology.

[83]  W. Leonard,et al.  Smad-dependent Cooperative Regulation of Interleukin 2 Receptor α Chain Gene Expression by T Cell Receptor and Transforming Growth Factor-β* , 2005, Journal of Biological Chemistry.

[84]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.

[85]  Ian A Wilson,et al.  Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[86]  W. Leonard,et al.  The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities. , 1987, Science.

[87]  L. Glimcher,et al.  NFATc1 and NFATc2 together control both T and B cell activation and differentiation. , 2001, Immunity.

[88]  L. Glimcher,et al.  Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. , 1998, Immunity.

[89]  F. Alt,et al.  Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.

[90]  B. Nelson,et al.  Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation , 1994, Nature.

[91]  T. Williams,et al.  Identification of a zinc finger protein that inhibits IL-2 gene expression. , 1991, Science.

[92]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[93]  Cynthia Wolberger,et al.  The Structure of GABPα/β: An ETS Domain- Ankyrin Repeat Heterodimer Bound to DNA , 1998 .

[94]  S. Ziegler,et al.  Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation* , 2001, The Journal of Biological Chemistry.

[95]  T. Ushijima,et al.  A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory , 2006, The EMBO journal.

[96]  E. Bettelli,et al.  Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[97]  G. Crabtree,et al.  Characterization of antigen receptor response elements within the interleukin-2 enhancer , 1988, Molecular and cellular biology.

[98]  Z. Dai,et al.  The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death. , 1999, Journal of immunology.

[99]  C. Kinnon,et al.  Defective expression of the interleukin-2/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency. , 2001, Blood.

[100]  T. Mak,et al.  Abnormal Development of Intestinal Intraepithelial Lymphocytes and Peripheral Natural Killer Cells in Mice Lacking the IL-2 Receptor β Chain , 1997, The Journal of experimental medicine.

[101]  M. Grilli,et al.  NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. , 1992, Science.

[102]  W. Greene,et al.  Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[103]  M. Shannon,et al.  The Human IL-2 Gene Promoter Can Assemble a Positioned Nucleosome That Becomes Remodeled Upon T Cell Activation1 , 2002, The Journal of Immunology.

[104]  C. Thompson,et al.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.

[105]  P. Lécine,et al.  IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells , 2000, Oncogene.

[106]  R. Tjian,et al.  Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. , 1986, Science.

[107]  H. Niida,et al.  The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. , 2000, Genes & development.

[108]  K P Lee,et al.  Differential T cell costimulatory requirements in CD28-deficient mice. , 1993, Science.

[109]  W. Greene,et al.  The same 50-kDa cellular protein binds to the negative regulatory elements of the interleukin 2 receptor alpha-chain gene and the human immunodeficiency virus type 1 long terminal repeat. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[110]  W. Cruikshank,et al.  Synergistic activation of CD4+ T cells by IL-16 and IL-2. , 1998, Journal of immunology.

[111]  S. L. Cross,et al.  Regulation of the human interleukin-2 receptor α chain promoter: Activation of a nonfunctional promoter by the transactivator gene of HTLV-I , 1987, Cell.

[112]  B. Cullen,et al.  Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. , 1986, Science.

[113]  K. Sugamura,et al.  Expression of the mouse interleukin‐2 receptor γ chain in various cell populations of the thymus and spleen , 1994, European journal of immunology.

[114]  C. Clendenin,et al.  Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB , 1996, Nature.

[115]  W. Leonard,et al.  The Basis for IL-2-Induced IL-2 Receptor α Chain Gene Regulation , 2001 .

[116]  E. Wagner,et al.  C-Jun Nh2-Terminal Kinase (Jnk)1 and Jnk2 Have Similar and Stage-Dependent Roles in Regulating T Cell Apoptosis and Proliferation , 2001, The Journal of experimental medicine.

[117]  Steven A. Rosenberg,et al.  Progress in human tumour immunology and immunotherapy , 2001, Nature.

[118]  P. Sassone-Corsi,et al.  Signaling routes to CREM and CREB: plasticity in transcriptional activation. , 1999, Trends in biochemical sciences.

[119]  A. Fischer,et al.  Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[120]  M. Naramura,et al.  Mice with a fluorescent marker for interleukin 2 gene activation. , 1998, Immunity.

[121]  E. Serfling,et al.  Octamer factors exert a dual effect on the IL-2 and IL-4 promoters. , 1994, Journal of immunology.

[122]  M. Erdos,et al.  Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signalling , 1994, Nature.

[123]  T. Malek,et al.  CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. , 2002, Immunity.

[124]  G. Tsokos,et al.  The Cyclic Adenosine 5′-Monophosphate Response Element Modulator Suppresses IL-2 Production in Stimulated T Cells by a Chromatin-Dependent Mechanism1 , 2003, The Journal of Immunology.

[125]  M. Nambiar,et al.  Antisense Cyclic Adenosine 5′-Monophosphate Response Element Modulator Up-Regulates IL-2 in T Cells from Patients with Systemic Lupus Erythematosus1 , 2002, The Journal of Immunology.

[126]  K. Garcia,et al.  Structure of the Quaternary Complex of Interleukin-2 with Its α, ß, and γc Receptors , 2005, Science.

[127]  W. Leonard,et al.  Characterization of the human interleukin-2 receptor gamma chain gene. , 1993, The Journal of biological chemistry.

[128]  G. Crabtree,et al.  Molecular cloning and expression of cDNAs for the human interleukin-2 receptor , 1984, Nature.

[129]  R. Schwartz,et al.  Biallelic expression of the IL‐2 locus under optimal stimulation conditions , 2000 .

[130]  J. Darnell,et al.  The Significance of Tetramerization in Promoter Recruitment by Stat5 , 1999, Molecular and Cellular Biology.

[131]  D. Olive,et al.  Temporal and Subunit-specific Modulations of the Rel/NF-κB Transcription Factors Through CD28 Costimulation* , 1997, The Journal of Biological Chemistry.

[132]  Y. Obata,et al.  NF-κB RelA-deficient Lymphocytes: Normal Development of  T Cells and B Cells, Impaired Production of IgA and IgG1 and Reduced Proliferative Responses , 1997, The Journal of experimental medicine.

[133]  W. Leonard,et al.  Binding of HMG-I(Y) Imparts Architectural Specificity to a Positioned Nucleosome on the Promoter of the Human Interleukin-2 Receptor α Gene , 2000, Molecular and Cellular Biology.

[134]  S. Thierfelder,et al.  Retinoid regulation of interleukin-2 receptors on human T-cells. , 1997, Cellular immunology.

[135]  R. Schwartz,et al.  The destabilization of IL-2 mRNA by a premature stop codon and its differential stabilization by trans-acting inhibitors of protein synthesis do not support a role for active translation in mRNA stability. , 1999, Journal of immunology.

[136]  M. Karin,et al.  Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. , 1998, Science.

[137]  A. Fischer,et al.  Tissue-specific Activity of the γc Chain Gene Promoter Depends upon an Ets Binding Site and Is Regulated by GA-binding Protein* , 1996, The Journal of Biological Chemistry.

[138]  A. Rao,et al.  Analysis of the AP-1 sites in the IL-2 promoter. , 1992, Journal of immunology.

[139]  W. Leonard,et al.  Functional cleavage of the common cytokine receptor γ chain (γc) by calpain , 1997 .

[140]  G. Crabtree,et al.  The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. , 1998, Immunity.

[141]  N. Bhat,et al.  Characterization of the human interleukin-2 receptor beta-chain gene promoter: regulation of promoter activity by ets gene products , 1993, Molecular and cellular biology.

[142]  Ronald H. Schwartz,et al.  Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process , 2003, Nature Immunology.

[143]  H. Dadi,et al.  Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor , 1997 .

[144]  F. Birg,et al.  Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. , 1992, Journal of immunology.

[145]  E. Rothenberg,et al.  A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[146]  A. Strasser,et al.  Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. , 1995, Genes & development.

[147]  W. Leonard,et al.  Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. , 1995, Immunity.

[148]  E. Rothenberg,et al.  A New Regulatory Region of the IL-2 Locus That Confers Position-Independent Transgene Expression1 , 2001, The Journal of Immunology.

[149]  T. Taniguchi.  Cytokine signaling through nonreceptor protein tyrosine kinases. , 1995, Science.

[150]  R. Gallo,et al.  Selective in vitro growth of T lymphocytes from normal human bone marrows. , 1976, Science.

[151]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[152]  S. L. Cross,et al.  Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes. , 1989, Science.

[153]  A. Strasser,et al.  Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[154]  D. Green,et al.  Activation‐induced cell death in T cells , 2003, Immunological reviews.

[155]  R. Buckley.  Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. , 2004, Annual review of immunology.

[156]  E. Serfling,et al.  The Interleukin 2 Receptor α Chain/CD25 Promoter Is a Target for Nuclear Factor of Activated T Cells , 1998, The Journal of experimental medicine.

[157]  P. Zipfel,et al.  The Early Growth Response Protein (EGR-1) Regulates Interleukin-2 Transcription by Synergistic Interaction with the Nuclear Factor of Activated T Cells* , 1998, The Journal of Biological Chemistry.

[158]  J. Ghysdael,et al.  Elf-1 Contributes to the Function of the Complex Interleukin (IL)-2–responsive Enhancer in the Mouse IL-2 Receptor α Gene , 1997, The Journal of experimental medicine.